Wird geladen...
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate. Survivors usually have low quality of life. Current clinical management strategies are respiratory support and restricted fluid input, and there is no suggested pharmacological treatment. Mesenchymal stromal c...
Gespeichert in:
| Veröffentlicht in: | Stem Cell Res Ther |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373844/ https://ncbi.nlm.nih.gov/pubmed/32698898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01804-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|